Recce Pharmaceuticals gets ethics green light for RECCE® 327 Gel clinical trials...
Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has garnered Human Research Ethics Committee (HREC) approval to commence a Phase 2 clinical trial of RECCE® 327 (R327) Gel for acute bacterial skin and skin structure infections (ABSSSI). The trial positions …